Cargando…
Polylactide Nanoparticles as a Biodegradable Vaccine Adjuvant: A Study on Safety, Protective Immunity and Efficacy against Human Leishmaniasis Caused by Leishmania Major
Leishmaniasis is the 3rd most challenging vector-borne disease after malaria and lymphatic filariasis. Currently, no vaccine candidate is approved or marketed against leishmaniasis due to difficulties in eliciting broad immune responses when using sub-unit vaccines. The aim of this work was the desi...
Autores principales: | Ayari-Riabi, Sana, Ben khalaf, Noureddine, Bouhaouala-Zahar, Balkiss, Verrier, Bernard, Trimaille, Thomas, Benlasfar, Zakaria, Chenik, Mehdi, Elayeb, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783570/ https://www.ncbi.nlm.nih.gov/pubmed/36557812 http://dx.doi.org/10.3390/molecules27248677 |
Ejemplares similares
-
A Polylactide-Based Micellar Adjuvant Improves the Intensity and Quality of Immune Response
por: Lamrayah, Myriam, et al.
Publicado: (2022) -
Inhibitory Potential of Polyclonal Camel Antibodies against New Delhi Metallo-β-lactamase-1 (NDM-1)
por: Ben Abderrazek, Rahma, et al.
Publicado: (2020) -
Leishmania major large RAB GTPase is highly immunogenic in individuals immune to cutaneous and visceral leishmaniasis
por: Chamakh-Ayari, Rym, et al.
Publicado: (2017) -
Neutralizing Dromedary-Derived Nanobodies Against BotI-Like Toxin From the Most Hazardous Scorpion Venom in the Middle East and North Africa Region
por: Ben Abderrazek, Rahma, et al.
Publicado: (2022) -
Xenopus Oocyte’s Conductance for Bioactive Compounds Screening and Characterization
por: Cheikh, Amani, et al.
Publicado: (2019)